Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
Press Releases
-
United Health Products Provides Update on FDA PMA Application Process
Mesquite, Nevada – March 29, 2023 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. As disclosed in a press release on January 31, 2023, UHP produced three batch lots of its HemoStyp gauze product to demonstrate consistent manufacturing results, which the company believes to […]
-
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
Mesquite, NV, Jan. 31, 2023 — United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application process and the amendment of its Agreement with White Lion Capital. UHP continues to advance its Premarket Approval application with the Food and Drug Administration. Last December, a batch lot of HemoStyp gauze […]
-
United Health Products Provides Update on Manufacturing and FDA PMA Application
MESQUITE, NV, Dec. 19, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. UHP continues to advance its Premarket Approval application with the Food and Drug Administration. The company has received and reviewed external laboratory test results on HemoStyp hemostatic gauze produced under its new […]
-
United Health Products Provides Update on FDA PMA Application
Mesquite, Nevada – Nov 28, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. UHP continues to advance its Premarket Approval application with the Food and Drug Administration. As described in its October 31 press release, the company has completed its review and documentation […]